Susan Acker-Walsh

Susan Acker-Walsh is a seasoned executive with extensive experience in strategic leadership and operations across diverse industries, particularly in health, drug development, and technology. As the CEO and Co-Founder of CREO since January 2016, Acker-Walsh addresses operational challenges faced by companies, ensuring focus on core objectives. Prior roles include COO at Clinipace Worldwide, Managing Partner at Acker-Walsh Leadership Consulting, President and COO at SciMetrika, VP & Operations Director at SRA International, and SVP at Constella Group. Acker-Walsh also led Blue292 as Chairwoman, President, and CEO, and contributed to significant growth at Analytical Sciences, Inc. Acker-Walsh holds an MBA in Strategy from UNC Kenan-Flagler Business School and a BA in History from Mount Saint Mary's University.